Jaguar Health Inc.
No price chart data available for 1D timeframe.
Rating
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Jaguar Health, Inc., a commercial-stage pharmaceutical firm, specializes in developing prescription therapies for both human and animal patients afflicted by gastrointestinal ailments, particularly ch...
Latest News
1 month ago · 247wallst.com
Viking Therapeutics Sinks 15% After Pricing Upsized $500M Offering; Jaguar Health Tumbles 25%Two biotech names are moving sharply lower Thursday morning while the sector benchmark grinds higher, a split move that puts the day's action on the companies themselves rather than on any broader rotation.
1 month ago · 247wallst.com
Two Biotechs Get Beaten Down: Jaguar Health Collapses 59%, Viking Therapeutics Sinks 4%Two biotechnology names are lower in Wednesday morning trading for unrelated reasons, and the biotechnology sector itself isn't selling off. Jaguar Health (NASDAQ:JAGX) stock is at $14.
1 month ago · benzinga.com
Jaguar Health Stock Plunges Wednesday: What's Happening?Jaguar Health Inc. (NASDAQ:JAGX) shares are plunging Wednesday morning as profit-taking reverses an explosive Tuesday rally sparked by regulatory fee waivers.
2 months ago · benzinga.com
Jaguar Health Stock Slides Thursday: What's Happening?Shares of Jaguar Health Inc. (NASDAQ:JAGX) are trading lower Thursday morning as investors evaluate the clinical development timeline for the company's rare pediatric disease pipeline following an operational update.
2 months ago · seekingalpha.com
Jaguar Health, Inc. (JAGX) Q2 2026 Earnings Call Prepared Remarks TranscriptJaguar Health, Inc. (JAGX) Q2 2026 Earnings Call Prepared Remarks Transcript
Add to Watchlist
Select watchlists to add or remove JAGX